Vitality Watch

Dossier pubmed preclinical 17-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo.

Key claim: K21, a silane antimicrobial, remodels macrophage mitochondrial metabolism via mitophagy, boosts antimicrobial activity, and extends lifespan in a model organism through an evolutionarily conserved mechanism.

Abstract

Multiple immune mechanisms must be coordinated to defend against a broad range of pathogens; however, the mechanisms by which broad-spectrum antipathogens act remain largely elusive. Here, we used systems biology approaches to understand the organization of human immune cells at the single-cell level and their reorganization in response to K21, a silane derivative effective against viral, bacterial, and fungal infections. K21 effectively reduced the infectivity ofwithin macrophages while improving bacterial phagocytosis by human monocyte-derived macrophages, in a manner similar to that of known mitophagy inducers. K21 induced pro-inflammatory pathways in M1 and M2 macrophages without altering cytokine secretion, decreased a specific subtype of M1 macrophages and M2c macrophages, and improved mitochondrial health by enhancing mitochondrial recycling via mitophagy. Similar treatment of the model organisminduced mitophagy and extended lifespan, suggesting an evolutionarily conserved mechanism. Our work demonstrates that a drug that remodels mitochondrial metabolism can reshape the immune cell repertoire, potentially aiding the development of more effective antimicrobials and helping to prevent the emergence of drug-resistant pathogens.

Why this matters

Repurposing a broad-spectrum antimicrobial as a mitophagy-engaging geroprotector is an unusual on-ramp: it collapses the antimicrobial-defense and mitochondrial-quality-control narratives into a single mechanism operating in macrophages. The evidence is preclinical cell and invertebrate work with a conserved-mechanism claim, so it sits well upstream of any human translation and inherits the standard model-organism-to-human transfer risk.

Source

Link

Briefing card

Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo.
Stage: preclinical · pubmed · 17-sep-2026

If you were tracking K21 as a longevity candidate, current evidence is preclinical macrophage and invertebrate-lifespan data — no human outcomes have been tested.

K21, a silane antimicrobial, remodels macrophage mitochondrial metabolism via mitophagy, boosts antimicrobial activity, and extends lifespan in a model organism through an evolutionarily conserved mechanism.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.26508/lsa.202603852

build build 880 · 2bcef25 · 2026-11-18